Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11 (2011), Pages 1726-1734
http://dx.doi.org/10.1100/2011/172893
Review Article

Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability

Centre for Neuroscience, Division of Experimental Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK

Received 6 June 2011; Accepted 24 August 2011

Academic Editor: R. E. Tanzi

Copyright © 2011 Marios Politis and Clare Loane. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [30 citations]

The following is the list of published articles that have cited the current article.

  • Marios Politis, and Clare Loane, “Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability,” Thescientificworldjournal, vol. 11, pp. 1726–1734, 2011. View at Publisher · View at Google Scholar
  • C. Loane, and M. Politis, “Buspirone: What is it all about?,” Brain Research, vol. 1461, pp. 111–118, 2012. View at Publisher · View at Google Scholar
  • S. Kim Kjaerulff, L. Wich, J. Kringelum, U. P. Jacobsen, I. Kouskoumvekaki, K. Audouze, O. Lund, S. Brunak, T. I. Oprea, and O. Taboureau, “ChemProt-2.0: visual navigation in a disease chemical biology database,” Nucleic Acids Research, vol. 41, no. D1, pp. D464–D469, 2012. View at Publisher · View at Google Scholar
  • N. Rampersaud, A. Harkavyi, G. Giordano, R. Lever, J. Whitton, and P.S. Whitton, “RETRACTED: Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson’s disease with combined noradrenergic and serotonergic lesions,” Neuropeptides, vol. 46, no. 5, pp. 183–193, 2012. View at Publisher · View at Google Scholar
  • Gaynor A. Smith, Ole Isacson, and Stephen B. Dunnett, “The search for genetic mouse models of prodromal Parkinson's disease,” Experimental Neurology, vol. 237, no. 2, pp. 267–273, 2012. View at Publisher · View at Google Scholar
  • Samuel W. Caito, William M. Valentine, and Michael Aschner, “ Dopaminergic neurotoxicity of S -ethyl N,N -dipropylthiocarbamate (EPTC), molinate, and S -methyl- N,N -diethylthiocarbamate (MeDETC) in Caenorhabditis elegans ,” Journal of Neurochemistry, 2013. View at Publisher · View at Google Scholar
  • Jason R. Cannon, Kindiya D. Geghman, Victor Tapias, Thomas Sew, Michelle K. Dail, Chenjian Li, and J. Timothy Greenamyre, “Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment,” Experimental Neurology, vol. 240, pp. 44–56, 2013. View at Publisher · View at Google Scholar
  • Marios Politis, and Flavia Niccolini, “Serotonin in Parkinson's disease,” Behavioural Brain Research, 2014. View at Publisher · View at Google Scholar
  • Xiong Zhang, Xing Cheng, Yan-Bing Hu, Jun-Mei Lai, Hui You, Pei-Long Hu, Ming Zou, and Jian-Hong Zhu, “Serotonin transporter polymorphic region 5-HTTLPR modulates risk for Parkinson’s disease,” Neurobiology of Aging, 2014. View at Publisher · View at Google Scholar
  • Marina A. Gruden, Tatiana V. Davydova, Victor B. Narkevich, Valentina G. Fomina, Chao Wang, Vladimir S. Kudrin, Ludmilla A. Morozova-Roche, and Robert D.E. Sewell, “Noradrenergic and serotonergic neurochemistry arising from intranasal inoculation with α-synuclein aggregates which incite parkinsonian-like symptoms,” Behavioural Brain Research, 2014. View at Publisher · View at Google Scholar
  • F. Niccolini, C. Loane, and M. Politis, “Dyskinesias in Parkinson's disease: views from positron emission tomography studies,” European Journal of Neurology, 2014. View at Publisher · View at Google Scholar
  • Qing Tong, Li Zhang, Yongsheng Yuan, Siming Jiang, Rui Zhang, Qinrong Xu, Jian Ding, Daqian Li, Xiaobin Zhou, and Kezhong Zhang, “Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson’s disease are associated with nonmotor symptoms,” Parkinsonism & Related Disorders, 2015. View at Publisher · View at Google Scholar
  • Lorenzo Rocchi, Flavia Niccolini, and Marios Politis, “Recent imaging advances in neurology,” Journal of Neurology, 2015. View at Publisher · View at Google Scholar
  • Ciara A. Martin, Katherine M. Myers, Audrey Chen, Nathan T. Martin, Angel Barajas, Felix E. Schweizer, and David E. Krantz, “Ziram, a pesticide associated with increased risk for Parkinson's disease, differentially affects the presynaptic function of aminergic and glutamatergic nerve terminals at the Drosophila neuromuscular junction,” Experimental Neurology, 2015. View at Publisher · View at Google Scholar
  • C L Bethea, and A P Reddy, “Ovarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques,” Molecular Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Pollyana C. Leal, Lívia C. R. F. Lins, Auderlan M. de Gois, Murilo Marchioro, and José R. Santos, “Commentary: Evaluation of Models of Parkinson's Disease,” Frontiers in Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Masanori Ikeda, Hiroshi Kataoka, and Satoshi Ueno, “Fatigue is associated with the onset of hallucinations in patients with Parkinson's disease: A 3-year prospective study,” eNeurologicalSci, 2016. View at Publisher · View at Google Scholar
  • Brit Mollenhauer, Lucilla Parnetti, Irena Rektorova, Milica G. Kramberger, Maria Pikkarainen, Walter J. Schulz-Schaeffer, Dag Aarsland, Per Svenningsson, Lucia Farotti, Marcel M. Verbeek, and Michael G. Schlossmacher, “Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders,” Journal of Neurochemistry, vol. 139, pp. 290–317, 2016. View at Publisher · View at Google Scholar
  • Daniella Rylander Ottosson, and Emma Lane, “Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?,” Frontiers in Cellular Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Li-Jun Zuo, Shu-Yang Yu, Yang Hu, Fang Wang, Ying-Shan Piao, Teng-Hong Lian, Qiu-Jin Yu, Rui-Dan Wang, Li-Xia Li, Peng Guo, Yang Du, Rong-Yan Zhu, Zhao Jin, Ya-Jie Wang, Xiao-Min Wang, Piu Chan, Sheng-Di Chen, Yong-Jun Wang, and Wei Zhang, “Serotonergic dysfunctions and abnormal iron metabolism: Relevant to mental fatigue of Parkinson disease,” Scientific Reports, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yasmina Mart?, Friederike Matthaeus, Thorsten Lau, and Patrick Schloss, “Methyl-4-phenylpyridinium (MPP +) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons,” Molecular and Cellular Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Carmelo M. Vicario, Robert D. Rafal, Davide Martino, and Alessio Avenanti, “Core, social and moral disgust are bounded: A review on cognitive and neural bases of repugnance in clinical disorders,” Neuroscience & Biobehavioral Reviews, 2017. View at Publisher · View at Google Scholar
  • Stefano Gambardella, Rosangela Ferese, Francesca Biagioni, Carla L. Busceti, Rosa Campopiano, Anna M. P. Griguoli, Fiona Limanaqi, Giuseppe Novelli, Marianna Storto, and Francesco Fornai, “The Monoamine Brainstem Reticular Formation as a Paradigm for Re-Defining Various Phenotypes of Parkinson’s Disease Owing Genetic and Anatomical Specificity,” Frontiers in Cellular Neuroscience, vol. 11, 2017. View at Publisher · View at Google Scholar
  • Gennaro Pagano, Flavia Niccolini, Paolo Fusar-Poli, and Marios Politis, “Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies,” Annals of Neurology, vol. 81, no. 2, pp. 171–180, 2017. View at Publisher · View at Google Scholar
  • Tayyabah Yousaf, Gennaro Pagano, Flavia Niccolini, and Marios Politis, “Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness,” Sleep Medicine, 2017. View at Publisher · View at Google Scholar
  • Gennaro Pagano, Flavia Niccolini, and Marios Politis, “The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies,” Journal of Neural Transmission, 2017. View at Publisher · View at Google Scholar
  • Hossein Sanjari Moghaddam, Ameneh Zare-Shahabadi, Farzaneh Rahmani, and Nima Rezaei, “Neurotransmission systems in Parkinson?s disease,” Reviews in the Neurosciences, no. 0, 2017. View at Publisher · View at Google Scholar
  • Sokhna M. S. Yakhine-Diop, Mario Rodríguez-Arribas, Guadalupe Martínez-Chacón, Elisabet Uribe-Carretero, Rubén Gómez-Sánchez, Ana Aiastui, Adolfo López de Munain, José M. Bravo-San Pedro, Mireia Niso-Santano, Rosa A. González-Polo, and José M. Fuentes, “Acetylome in Human Fibroblasts From Parkinson's Disease Patients,” Frontiers in Cellular Neuroscience, vol. 12, 2018. View at Publisher · View at Google Scholar
  • Lívia H. Morais, Daniela B. Hara, Maíra A. Bicca, Anicleto Poli, and Reinaldo N. Takahashi, “Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson’s disease,” Behavioural Pharmacology, vol. 29, pp. 199–210, 2018. View at Publisher · View at Google Scholar
  • Ivana Cacciatore, Michele Ciulla, Lisa Marinelli, Piera Eusepi, and Antonio Di Stefano, “Advances in prodrug design for Parkinson’s disease,” Expert Opinion on Drug Discovery, pp. 1–11, 2018. View at Publisher · View at Google Scholar